Pharmacology and neurotoxicity of cis-diamminedichloroplatinum, bleomycin, 5-fluorouracil, and cyclophosphamide administration following osmotic blood-brain barrier modification.

作者: Edward A. Neuwelt , Eugene P. Frenkel , Peggy A. Barnett , Mark Glasberg

DOI:

关键词:

摘要: cis-Platinum, bleomycin, 5-fluorouracil, and cyclophosphamide were administered to rodent canine models of osmotic blood-brain barrier modification evaluate the relationship between tissue drug concentration in brain physiological neuropathological effects drug. The toxicity studies carried out canine, pharmacological rodent. Even without procedure, intracarotid cis-platinum, contrast other drugs, produced with resultant severe neurotoxicity. Osmotic was used increase delivery bleomycin 5-fluorouracil ipsilateral region, but increased associated evident Cyclophosphamide administration association opening did not cause significant neural toxicity. These indicate that some chemotherapeutic agents given can result corollary known limited neurotoxicity when these are a conventional manner appears be due presence barrier.

参考文章(20)
Edward A. Neuwelt, Eugene P. Frenkel, Mark Glassberg, Michael Pagel, Peggy Barnett, Pharmacology and Toxicity of Intracarotid Adriamycin Administration Following Osmotic Blood-Brain Barrier Modification Cancer Research. ,vol. 41, pp. 4466- 4470 ,(1981)
Charles R. West, Girish Chheda, Donald B. Tower, Robert S. Bourke, Kinetics of Entry and Distribution of 5-Fluorouracil in Cerebrospinal Fluid and Brain following Intravenous Injection in a Primate Cancer Research. ,vol. 33, pp. 1735- 1746 ,(1973)
S. I. Rapoport, W. R. Fredericks, K. Ohno, K. D. Pettigrew, Quantitative aspects of reversible osmotic opening of the blood-brain barrier American Journal of Physiology-regulatory Integrative and Comparative Physiology. ,vol. 238, ,(1980) , 10.1152/AJPREGU.1980.238.5.R421
Edward A. Neuwelt, Eugene P. Frenkel, J. Diehl, L. H. Vu, Stanley Rapoport, Suellen Hill, Reversible osmotic blood-brain barrier disruption in humans: implications for the chemotherapy of malignant brain tumors. Neurosurgery. ,vol. 7, pp. 44- 52 ,(1980) , 10.1227/00006123-198007000-00007
Edward A. Neuwelt, Eugene P. Frenkel, Stanley Rapoport, Peggy Barnett, Effect of osmotic blood-brain barrier disruption on methotrexate pharmacokinetics in the dog. Neurosurgery. ,vol. 7, pp. 36- 43 ,(1980) , 10.1227/00006123-198007000-00006
Henry T. Lynch, Catherine P. Droszcz, William A. Albano, Jane F. Lynch, “Organic brain syndrome” secondary to 5-fluorouracil toxicity Diseases of The Colon & Rectum. ,vol. 24, pp. 130- 131 ,(1981) , 10.1007/BF02604302
E A Neuwelt, K R Maravilla, E P Frenkel, S I Rapaport, S A Hill, P A Barnett, Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery. Journal of Clinical Investigation. ,vol. 64, pp. 684- 688 ,(1979) , 10.1172/JCI109509
EDWARD A NEUWELT, JAN T DIEHL, LONG H VU, SUELLEN A HILL, ANDREW J MICHAEL, EUGENE P FRENKEL, Monitoring of Methotrexate Delivery in Patients with Malignant Brain Tumors After Osmotic Blood-Brain Barrier Disruption Annals of Internal Medicine. ,vol. 94, pp. 449- 454 ,(1981) , 10.7326/0003-4819-94-4-449
Edward A. Neuwelt, Edward Balaban, Jan Diehl, Suellen Hill, Eugene Frenkel, Successful treatment of primary central nervous system lymphomas with chemotherapy after osmotic blood-brain barrier opening Neurosurgery. ,vol. 12, pp. 662- 671 ,(1983) , 10.1227/00006123-198306000-00013